Northern Trust Corp Acquires 39,198 Shares of Prestige Consumer Healthcare Inc. $PBH

Key Points

• Northern Trust Corp increased its stake in Prestige Consumer Healthcare by 4.8%, acquiring an additional 39,198 shares, bringing its total ownership to approximately 1.72% valued at $73.27 million.
• The stock opened at $65.69, with a market cap of $3.23 billion, and has reported a net margin of 19.02% and quarterly revenue decline of 6.6% compared to last year.
• Analyst ratings are mixed, with the stock having three buy ratings and three hold ratings, and an average price target of $93.33 according to MarketBeat data.

Northern Trust Corp grew its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 4.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 852,274 shares of the company's stock after buying an additional 39,198 shares during the period. Northern Trust Corp owned approximately 1.72% of Prestige Consumer Healthcare worth $73,270,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC boosted its holdings in Prestige Consumer Healthcare by 35.9% during the first quarter. GAMMA Investing LLC now owns 1,879 shares of the company's stock worth $162,000 after buying an additional 496 shares during the last quarter. KBC Group NV boosted its holdings in Prestige Consumer Healthcare by 7.4% during the first quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after buying an additional 151 shares during the last quarter. QRG Capital Management Inc. boosted its holdings in Prestige Consumer Healthcare by 8.6% during the first quarter. QRG Capital Management Inc. now owns 5,971 shares of the company's stock worth $513,000 after buying an additional 475 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in Prestige Consumer Healthcare by 1,073.3% during the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock worth $15,923,000 after buying an additional 186,524 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in Prestige Consumer Healthcare by 14.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 8,315 shares of the company's stock worth $649,000 after buying an additional 1,030 shares during the last quarter. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Up 0.6%

Shares of NYSE:PBH traded up $0.41 during trading on Thursday, hitting $67.37. 676,013 shares of the company were exchanged, compared to its average volume of 602,764. The stock has a market cap of $3.32 billion, a price-to-earnings ratio of 15.81, a P/E/G ratio of 2.11 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.95 and a fifty-two week high of $90.04. The firm has a fifty day moving average price of $73.94 and a two-hundred day moving average price of $80.70. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.06). The company had revenue of $249.53 million for the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The firm's revenue for the quarter was down 6.6% compared to the same quarter last year. During the same period last year, the firm earned $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on PBH shares. Canaccord Genuity Group reduced their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Wall Street Zen lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, Royal Bank Of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.